Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis.
Sindre Lee-ØdegårdMarit HjorthThomas OlsenGunn-Helen MoenEmily DaubneyDavid M EvansAndrea L HevenerAldons J LusisMingqi ZhouMarcus M SeldinHooman AllayeeJames HilserJonas Krag VikenHanne GulsethFrode NorheimChristian A DrevonKåre Inge BirkelandPublished in: eLife (2024)
clinicaltrials.gov: NCT01803568.